Biosimilar use in medical oncology in Ireland: a missed opportunity to mitigate financial toxicity?
Saved in:
| Title: | Biosimilar use in medical oncology in Ireland: a missed opportunity to mitigate financial toxicity? |
|---|---|
| Authors: | Burton E; Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, College Road, Cork, Ireland. edel.burton@ucc.ie.; School of Public Health, University College Cork, Cork, Ireland. edel.burton@ucc.ie.; Pharmacy Department, Bon Secours Hospital, Cork, Ireland. edel.burton@ucc.ie., Coakley KE; Department of Medical Oncology, Beaumount Hospital, Dublin, Ireland., Gaynor S; Patient and Public Involvement Contributor -Patient Consultative Committee, Cancer Trials Ireland, Dublin, Ireland., McDonagh M; Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, College Road, Cork, Ireland., Palmer C; Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, College Road, Cork, Ireland., Sahm LJ; Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, College Road, Cork, Ireland.; Pharmacy Department, Mercy University Hospital, Cork, Ireland.; St. Patrick's Mental Health Services, Dublin, Ireland., O'Reilly S; Cancer Research @UCC, University College Cork, Cork, Ireland.; Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland. |
| Corporate Authors: | Biologics Impact on Patient Care and Treatment (Bio ImPAcT) Consortium |
| Source: | International journal of clinical pharmacy [Int J Clin Pharm] 2026 Jul 24. Date of Electronic Publication: 2026 Jul 24. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42496963 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Biosimilar use in medical oncology in Ireland: a missed opportunity to mitigate financial toxicity? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burton+E%22">Burton E</searchLink>; Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, College Road, Cork, Ireland. edel.burton@ucc.ie.; School of Public Health, University College Cork, Cork, Ireland. edel.burton@ucc.ie.; Pharmacy Department, Bon Secours Hospital, Cork, Ireland. edel.burton@ucc.ie.<br /><searchLink fieldCode="AU" term="%22Coakley+KE%22">Coakley KE</searchLink>; Department of Medical Oncology, Beaumount Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Gaynor+S%22">Gaynor S</searchLink>; Patient and Public Involvement Contributor -Patient Consultative Committee, Cancer Trials Ireland, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22McDonagh+M%22">McDonagh M</searchLink>; Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, College Road, Cork, Ireland.<br /><searchLink fieldCode="AU" term="%22Palmer+C%22">Palmer C</searchLink>; Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, College Road, Cork, Ireland.<br /><searchLink fieldCode="AU" term="%22Sahm+LJ%22">Sahm LJ</searchLink>; Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, College Road, Cork, Ireland.; Pharmacy Department, Mercy University Hospital, Cork, Ireland.; St. Patrick's Mental Health Services, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22O'Reilly+S%22">O'Reilly S</searchLink>; Cancer Research @UCC, University College Cork, Cork, Ireland.; Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Biologics+Impact+on+Patient+Care+and+Treatment+%28Bio+ImPAcT%29+Consortium%22">Biologics Impact on Patient Care and Treatment (Bio ImPAcT) Consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101554912%22">International journal of clinical pharmacy</searchLink> [Int J Clin Pharm] 2026 Jul 24. <i>Date of Electronic Publication: </i>2026 Jul 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101554912 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2210-7711 (Electronic) <i>NLM ISO Abbreviation: </i>Int J Clin Pharm <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42496963 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11096-026-02192-2 Languages: – Code: eng Text: English Titles: – TitleFull: Biosimilar use in medical oncology in Ireland: a missed opportunity to mitigate financial toxicity? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burton E – PersonEntity: Name: NameFull: Coakley KE – PersonEntity: Name: NameFull: Gaynor S – PersonEntity: Name: NameFull: McDonagh M – PersonEntity: Name: NameFull: Palmer C – PersonEntity: Name: NameFull: Sahm LJ – PersonEntity: Name: NameFull: O'Reilly S IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 07 Text: 2026 Jul 24 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2210-7711 Titles: – TitleFull: International journal of clinical pharmacy Type: main |
| ResultId | 1 |
